Amedisys reported a net service revenue increase of $24.4 million, reaching $491.7 million. Net income attributable to Amedisys, Inc. rose to $31.8 million, with diluted earnings per share at $0.96. The company withdrew its full-year 2020 guidance due to the uncertainty caused by COVID-19.
Net service revenue increased to $491.7 million from $467.3 million in the previous year.
Net income attributable to Amedisys, Inc. increased to $31.8 million from $31.3 million in the previous year.
Diluted earnings per share increased to $0.96 from $0.95 in the previous year.
Full-year 2020 guidance was withdrawn due to the impact of COVID-19.
Amedisys withdrew its full-year 2020 guidance due to the rapidly changing operating conditions related to the COVID-19 pandemic.